Research - Trillium Therapeutics (TSX:TR) (OTC:SCTPF) is an immuno-oncology company developing novel cancer therapeutics. Trillium was founded in 2003 and went public on the Toronto exchange via … Continue Reading
Read nowInsights - On Monday morning, Sarepta Therapeutics (SRPT) held a teleconference concerning regulatory updates for Eteplirsen, the company’s lead drug candidate for Duchenne Muscular Dystrophy. In a Type B … Continue Reading
Read nowResearch - Bluebird bio (BLUE) develops gene therapy products for diseases with significant unmet needs. Leveraging a proprietary lentiviral gene therapy platform, Bluebird currently has three core clinical … Continue Reading
PremiumInsights - Tekmira Pharmaceuticals (TKMR) and European drug developer Bavarian Nordic (BAVA.CO) are receiving significant attention in early trading on Wednesday morning with announcements that their two … Continue Reading
Read nowInsights - Agios Pharmaceuticals (AGIO) announced on Tuesday the initiation of a phase I/II multicenter study of AG-221 in patients with advanced solid tumors that carry an … Continue Reading
Read nowInsights - Tekmira (TKMR) revealed the first data for TKM-HBV publicly on Wednesday at a medical conference. Though early, Mr. Fink likes what he sees.
Read now
